Revised SPC: Zyban (bupropion hydrochloride) 150 mg prolonged release tablets

SPC updated to include aggravation of Systemic lupus erythematosus syndrome and cutaneous lupus erythematosus as undesirable effects of unknown frequency.

Source:

electronic Medicines compendium